135 related articles for article (PubMed ID: 36174417)
1. A serum metabolomics study based on LC-MS: Chemosensitization effects of Rauvolfia vomitoria Afzel. combined with 5- fluorouracil on colorectal cancer mice.
Wang ZF; Kong WR; Wang N; You YL; Wang JF; Wang SQ
J Pharm Biomed Anal; 2022 Nov; 221():115074. PubMed ID: 36174417
[TBL] [Abstract][Full Text] [Related]
2. ROS/PI3K/Akt and Wnt/β-catenin signalings activate HIF-1α-induced metabolic reprogramming to impart 5-fluorouracil resistance in colorectal cancer.
Dong S; Liang S; Cheng Z; Zhang X; Luo L; Li L; Zhang W; Li S; Xu Q; Zhong M; Zhu J; Zhang G; Hu S
J Exp Clin Cancer Res; 2022 Jan; 41(1):15. PubMed ID: 34998404
[TBL] [Abstract][Full Text] [Related]
3. Identification of chemosensitizing agents of colorectal cancer in
Cui WL; Guo DX; Wang N; Wang ZF; Ji JB; Wang X; Yang CG; Lin YQ; Wang SQ
Front Chem; 2022; 10():1069591. PubMed ID: 36688051
[TBL] [Abstract][Full Text] [Related]
4. Enhancing 5-fluorouracil efficacy through suppression of PKM2 in colorectal cancer cells.
Cao Y; Lin Y; Wang D; Pan D; Zhang Y; Jin Y; Zheng C
Cancer Chemother Pharmacol; 2018 Dec; 82(6):1081-1086. PubMed ID: 30155759
[TBL] [Abstract][Full Text] [Related]
5. Identification of Genes Related to 5-Fluorouracil Based Chemotherapy for Colorectal Cancer.
Huang X; Ke K; Jin W; Zhu Q; Zhu Q; Mei R; Zhang R; Yu S; Shou L; Sun X; Feng J; Duan T; Mou Y; Xie T; Wu Q; Sui X
Front Immunol; 2022; 13():887048. PubMed ID: 35784334
[TBL] [Abstract][Full Text] [Related]
6. Exploring the anti-metastatic effects of Astragalus mongholicus Bunge-Curcuma aromatica Salisb. on colorectal cancer: A network-based metabolomics and pharmacology approach.
Liang ZQ; Bian Y; Gu JF; Yin G; Sun RL; Liang Y; Wan LL; Yin QH; Wang X; Gao J; Zhao F; Tang C
Phytomedicine; 2023 Jun; 114():154772. PubMed ID: 37015187
[TBL] [Abstract][Full Text] [Related]
7. Standardization parameters and synergism of source plant materials for the antidiabetic efficacy of the Rauvolfia-Citrus tea.
Campbell-Tofte J; Mu H; Winther K; Mølgaard P; Belin N; Josefsen K
Fitoterapia; 2024 Jul; 176():106004. PubMed ID: 38744382
[TBL] [Abstract][Full Text] [Related]
8. GOLPH3 predicts survival of colorectal cancer patients treated with 5-fluorouracil-based adjuvant chemotherapy.
Wang Z; Jiang B; Chen L; Di J; Cui M; Liu M; Ma Y; Yang H; Xing J; Zhang C; Yao Z; Zhang N; Dong B; Ji J; Su X
J Transl Med; 2014 Jan; 12():15. PubMed ID: 24444035
[TBL] [Abstract][Full Text] [Related]
9. Curcumin, calebin A and chemosensitization: How are they linked to colorectal cancer?
Brockmueller A; Samuel SM; Mazurakova A; Büsselberg D; Kubatka P; Shakibaei M
Life Sci; 2023 Apr; 318():121504. PubMed ID: 36813082
[TBL] [Abstract][Full Text] [Related]
10. 5-fluorouracil and other fluoropyrimidines in colorectal cancer: Past, present and future.
Vodenkova S; Buchler T; Cervena K; Veskrnova V; Vodicka P; Vymetalkova V
Pharmacol Ther; 2020 Feb; 206():107447. PubMed ID: 31756363
[TBL] [Abstract][Full Text] [Related]
11. Quinacrine-Mediated Inhibition of Nrf2 Reverses Hypoxia-Induced 5-Fluorouracil Resistance in Colorectal Cancer.
Kim HG; Kim CW; Lee DH; Lee JS; Oh ET; Park HJ
Int J Mol Sci; 2019 Sep; 20(18):. PubMed ID: 31491980
[TBL] [Abstract][Full Text] [Related]
12. LC-MS/MS method for simultaneous analysis of uracil, 5,6-dihydrouracil, 5-fluorouracil and 5-fluoro-5,6-dihydrouracil in human plasma for therapeutic drug monitoring and toxicity prediction in cancer patients.
Büchel B; Rhyn P; Schürch S; Bühr C; Amstutz U; Largiadèr CR
Biomed Chromatogr; 2013 Jan; 27(1):7-16. PubMed ID: 22454320
[TBL] [Abstract][Full Text] [Related]
13. miR-139-5p sensitizes colorectal cancer cells to 5-fluorouracil by targeting NOTCH-1.
Liu H; Yin Y; Hu Y; Feng Y; Bian Z; Yao S; Li M; You Q; Huang Z
Pathol Res Pract; 2016 Jul; 212(7):643-9. PubMed ID: 27173050
[TBL] [Abstract][Full Text] [Related]
14. Correlation between pharmacokinetic parameters of 5-fluorouracil and related metabolites and adverse reactions in East-Asian patients with advanced colorectal cancer.
Tong Z; Cheng M; Yu Y; Yu J; Yin Y; Liu J; Zhang S; Jiang S; Dong M
Cancer Chemother Pharmacol; 2022 Mar; 89(3):323-330. PubMed ID: 35067736
[TBL] [Abstract][Full Text] [Related]
15. Resveratrol induces chemosensitization to 5-fluorouracil through up-regulation of intercellular junctions, Epithelial-to-mesenchymal transition and apoptosis in colorectal cancer.
Buhrmann C; Shayan P; Kraehe P; Popper B; Goel A; Shakibaei M
Biochem Pharmacol; 2015 Nov; 98(1):51-68. PubMed ID: 26310874
[TBL] [Abstract][Full Text] [Related]
16. Bevacizumab-enhanced antitumor effect of 5-fluorouracil via upregulation of thymidine phosphorylase through vascular endothelial growth factor A/vascular endothelial growth factor receptor 2-specificity protein 1 pathway.
Liu W; Zhang J; Yao X; Jiang C; Ni P; Cheng L; Liu J; Ni S; Chen Q; Li Q; Zhou K; Wang G; Zhou F
Cancer Sci; 2018 Oct; 109(10):3294-3304. PubMed ID: 30151975
[TBL] [Abstract][Full Text] [Related]
17. Synergistic antitumor activity of 5-fluorouracil and atosiban against microsatellite stable colorectal cancer through restoring GATA3.
Wang M; Guo X; Yang M; Zhang Y; Meng F; Chen Y; Chen M; Qiu T; Li J; Li Z; Zhang Q; Xu F; Zhang H; Wang W
Biochem Pharmacol; 2022 May; 199():115025. PubMed ID: 35367196
[TBL] [Abstract][Full Text] [Related]
18. Deciphering the metabolic profile and anti-colorectal cancer mechanism of Capilliposide A using ultra performance liquid chromatography mass spectrometry combined with non-targeted metabolomics studies.
Li W; Zhang X; Feng Y; Han H; Cai J; Zhao H; Li S; Tian J; Zhu W
J Pharm Biomed Anal; 2023 Sep; 234():115548. PubMed ID: 37390605
[TBL] [Abstract][Full Text] [Related]
19. MicroRNA-375-3p enhances chemosensitivity to 5-fluorouracil by targeting thymidylate synthase in colorectal cancer.
Xu F; Ye ML; Zhang YP; Li WJ; Li MT; Wang HZ; Qiu X; Xu Y; Yin JW; Hu Q; Wei WH; Chang Y; Liu L; Zhao Q
Cancer Sci; 2020 May; 111(5):1528-1541. PubMed ID: 32073706
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of GOT1 sensitizes colorectal cancer cells to 5-fluorouracil.
Hong C; Zheng J; Li X
Cancer Chemother Pharmacol; 2017 Apr; 79(4):835-840. PubMed ID: 28314989
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]